Research project: ATTACK: Aspirin to target arterial events in Chronic Kidney Disease
Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?
Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?
This multicentre randomised trial will assess the effectiveness of low dose aspirin to prevent cardiovascular disease (CVD) in adult patients with chronic kidney disease(CKD). There is uncertainty about the benefits (vs CVD) and harms (bleeding) of aspirin in such patients. CKD is common and the frequency is rising and it is associated with increased risk of CVD.
Local Investigators: Roderick P, Moore M, Lord J, Maishman T, Mark Lown
Study team: CI Gallagher H (Epsom and St Helier University Hospital), Dumbleton J (Nottingham University), Anson-Wisniewsksa K (Southampton)
Funder: NIHR HTA, British Heart Foundation
Duration: Start date 2018 End date 2025
Contact: pjr@soton.ac.uk
Website: https://www.southampton.ac.uk/attack-trial/index.page?